Recall archive
27 recalls · page 1 of 2
Reported Apr 15, 2026
Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand — Lack of Assurance of Sterility
FDA (openFDA drug enforcement)
Reported Dec 24, 2025
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details · Reason for recall — Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
FDA (openFDA drug enforcement)
Reported May 7, 2025
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — cGMP Deviations
FDA (openFDA drug enforcement)
Reported Sep 4, 2024
Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand — Failed Impurities/Degradation Specifications - at 18-month Stability testing
FDA (openFDA drug enforcement)
Reported May 29, 2024
Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
FDA (openFDA drug enforcement)
Reported Jul 12, 2023
Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC:…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand — Failed Stability Specifications
FDA (openFDA drug enforcement)
Reported Apr 12, 2023
Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by:…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details · Reason for recall — CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
19 more products in this recall
FDA (openFDA drug enforcement)
Reported Feb 1, 2023
Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack…
FDA (openFDA drug enforcement)
Reported Jun 1, 2022
Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand — CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
1 more product in this recall
FDA (openFDA drug enforcement)
Reported May 4, 2022
Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
FDA (openFDA drug enforcement)
Reported Apr 27, 2022
Diclofenac Sodium Topical Solution 1.5% w/w, Generic for Pennsaid, 150 ml bottle, Rx Only, Mfg: Sola Pharmaceutical,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability…
FDA (openFDA drug enforcement)
Reported Apr 20, 2022
Clobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx Only, Mfg: Teligent Pharma, Inc., PREFERRED…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability…
2 more products in this recall
FDA (openFDA drug enforcement)
Reported Mar 9, 2022
Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — CGMP deviations
FDA (openFDA drug enforcement)
Reported Dec 22, 2021
Diclofenac Sodium Topical Solution, 1.5% w/w, packaged in 150 mL bottles, Rx only, Mfg: SOLA Pharmaceuticals Preferred…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — Defective container: Out of specification for container integrity leading to bottles leaking.
FDA (openFDA drug enforcement)
Reported May 26, 2021
Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.
FDA (openFDA drug enforcement)
Reported May 5, 2021
Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified…
FDA (openFDA drug enforcement)
Reported Nov 25, 2020
Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.;…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
FDA (openFDA drug enforcement)
Reported Sep 30, 2020
Nature-Throid, 1/2 Grain, 32.5 mg (Thyroid U.S.P. 1/2 gr. (32.5 mg)/Liothyronine (T3) 4.5mcg/Levothyroxine (T4) 19mch,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — CGMP Deviations
3 more products in this recall
FDA (openFDA drug enforcement)
Reported Jul 22, 2020
Lidothol Patch, Lidocaine 4.5% & Menthol 5%, In each patch: lidocaine 4.5% topical anesthetic, menthol 5% topical…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch.
FDA (openFDA drug enforcement)
Reported Jul 8, 2020
Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc.,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
FDA (openFDA drug enforcement)
Reported Dec 4, 2019
Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg:…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
FDA (openFDA drug enforcement)
Reported Oct 2, 2019
Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc.,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — Failed Impurities/Degradation Specifications
FDA (openFDA drug enforcement)
Reported Jul 31, 2019
Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg Ophthalmic Ointment, Pkg Size 3 g Tube,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
FDA (openFDA drug enforcement)
Reported Jun 26, 2019
Robafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextromethorphan HBr, USP 10mg,/Guaifenesin, USP…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
FDA (openFDA drug enforcement)
RecallNow is not a government agency. Every notice above is published by the FDA, USDA FSIS, or CPSC and links back to its source. Back to the look-up